![Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis - Gastroenterology Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/892cc1be-aa85-4c64-a40f-4e34d5f28ffd/fx1_lrg.jpg)
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis - Gastroenterology
![Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art - ScienceDirect Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0939641121002010-ga1.jpg)
Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art - ScienceDirect
![Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines | Chinese Medicine | Full Text Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines | Chinese Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13020-020-0296-z/MediaObjects/13020_2020_296_Fig1_HTML.png)
Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines | Chinese Medicine | Full Text
![pH‑dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review) pH‑dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review)](https://www.spandidos-publications.com/article_images/br/15/5/br-15-05-01472-g00.jpg)
pH‑dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review)
![Some putative molecular mechanisms that underlie the antineoplastic... | Download Scientific Diagram Some putative molecular mechanisms that underlie the antineoplastic... | Download Scientific Diagram](https://www.researchgate.net/profile/Carmine-Stolfi/publication/23149277/figure/fig1/AS:601705553096713@1520469191704/Some-putative-molecular-mechanisms-that-underlie-the-antineoplastic-activity-of_Q640.jpg)
Some putative molecular mechanisms that underlie the antineoplastic... | Download Scientific Diagram
![Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncpgasthep0696/MediaObjects/41575_2007_Article_BFncpgasthep0696_Fig2_HTML.jpg)
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
![PHARMACOLOGY OF COMBINED MESALZINE AND RIFAXIMIN THERAPY TO INFLAMMATORY BOWEL DISEASE | PharmaTutor PHARMACOLOGY OF COMBINED MESALZINE AND RIFAXIMIN THERAPY TO INFLAMMATORY BOWEL DISEASE | PharmaTutor](http://4.bp.blogspot.com/-nBNTIdX5RDs/VpyDpsx7yNI/AAAAAAAAFro/N-UV2ee5aQg/s1600/pt-art-2412-3.jpg)
PHARMACOLOGY OF COMBINED MESALZINE AND RIFAXIMIN THERAPY TO INFLAMMATORY BOWEL DISEASE | PharmaTutor
![Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/29c69703-23fc-427e-8d46-49068c2f0a99/apt_3069_f2.gif)
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
![Frontiers | Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases | Cell and Developmental Biology Frontiers | Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/612830/fcell-09-612830-HTML/image_m/fcell-09-612830-g001.jpg)
Frontiers | Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases | Cell and Developmental Biology
![Some putative molecular mechanisms that underlie the antineoplastic... | Download Scientific Diagram Some putative molecular mechanisms that underlie the antineoplastic... | Download Scientific Diagram](https://www.researchgate.net/profile/Carmine-Stolfi/publication/23149277/figure/fig1/AS:601705553096713@1520469191704/Some-putative-molecular-mechanisms-that-underlie-the-antineoplastic-activity-of.png)
Some putative molecular mechanisms that underlie the antineoplastic... | Download Scientific Diagram
![Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease - Allgayer - 2003 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease - Allgayer - 2003 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/361797f6-ca16-43ef-8441-d31d24ff7613/apt_1696_f2.gif)
Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease - Allgayer - 2003 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
![Cureus | Efficacy and Safety of Vedolizumab in Management of Moderate to Severe Ulcerative Colitis: A Systematic Review Cureus | Efficacy and Safety of Vedolizumab in Management of Moderate to Severe Ulcerative Colitis: A Systematic Review](https://assets.cureus.com/uploads/figure/file/243323/lightbox_f27e2510ed9711eba94c1b194e928bb6-Figure1.png)
Cureus | Efficacy and Safety of Vedolizumab in Management of Moderate to Severe Ulcerative Colitis: A Systematic Review
![Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6af47296-2b66-41fd-b3d5-91a7df7c0b90/gr1_lrg.jpg)